According to West Pharmaceutical's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.48. At the end of 2024 the company had a P/S ratio of 8.34.
Year | P/S ratio | Change |
---|---|---|
2024 | 8.34 | -5.56% |
2023 | 8.83 | 46.34% |
2022 | 6.04 | -50.81% |
2021 | 12.3 | 25.78% |
2020 | 9.76 | 61.13% |
2019 | 6.05 | 43.14% |
2018 | 4.23 | -7.68% |
2017 | 4.58 | 11.37% |
2016 | 4.11 | 32.26% |
2015 | 3.11 | 16.47% |
2014 | 2.67 | 6.11% |
2013 | 2.52 | 69.72% |
2012 | 1.48 | 38.18% |
2011 | 1.07 | -13.59% |
2010 | 1.24 | 1.35% |
2009 | 1.23 | 4.22% |
2008 | 1.18 | -8.52% |
2007 | 1.29 | -30.36% |
2006 | 1.85 | 62.67% |
2005 | 1.13 | -21.15% |
2004 | 1.44 | 42.34% |
2003 | 1.01 | 19.85% |
2002 | 0.8434 | -19.72% |
2001 | 1.05 |